ProKidney Corp | Small-cap | Healthcare
$0.59
-11.49%
| ProKidney Stock Comparison:
ProKidney vs VertexProKidney vs RegeneronProKidney vs Vera TherapeuticsProKidney vs Immunocore HoldingsProKidney vs AgiosProKidney vs S&P 500 | Market
Overview Income Statement Balance Sheet Cash Flow Key Ratios Peer Comparison

Financial Overview

Latest Annual: 2024

Income Metrics

Revenue 76.0K
Operating Income -183.7M -241,678.95%
Net Income -163.3M -214,914.47%
EPS (Diluted) -$0.62

Balance Sheet Metrics

Total Assets 441.1M
Total Liabilities 39.4M
Shareholders Equity 401.6M
Debt to Equity 0.10

Cash Flow Metrics

Operating Cash Flow -118.2M
Free Cash Flow -155.9M

Revenue & Profitability Trend

ProKidney Income Statement From 2020 to 2024

Metric 2024 2023 2022 2021 2020
Revenue 76.0K 0 0 0 0
Cost of Goods Sold - - - - -
Gross Profit - - - - -
Operating Expenses 183.8M 151.5M 153.0M 55.1M 27.0M
Operating Income -183.7M -151.5M -153.0M -55.1M -27.0M
Pre-tax Income -163.9M -129.5M -147.2M -55.1M -27.0M
Income Tax -598.0K 6.0M 896.0K 38.0K -232.0K
Net Income -163.3M -135.4M -148.1M -55.1M -26.7M
EPS (Diluted) -$0.62 -$0.57 -$0.23 -$0.30 -$0.14

Income Statement Trend

ProKidney Balance Sheet From 2020 to 2024

Metric 2024 2023 2022 2021 2020
Assets
Current Assets 395.9M 374.1M 504.7M 27.3M 5.6M
Non-Current Assets 45.2M 46.4M 13.3M 13.0M 11.1M
Total Assets 441.1M 420.6M 518.0M 40.3M 16.7M
Liabilities
Current Liabilities 36.2M 25.0M 10.9M 12.3M 5.5M
Non-Current Liabilities 3.2M 4.2M 2.2M 1.1M 1.3M
Total Liabilities 39.4M 29.2M 13.1M 13.4M 6.8M
Equity
Total Shareholders Equity 401.6M 391.3M 504.9M 26.9M 9.9M

Balance Sheet Composition

ProKidney Cash Flow Statement From 2020 to 2024

Metric 2024 2023 2022 2021 2020
Operating Activities
Net Income -163.3M -135.4M -148.1M -55.1M -26.7M
Operating Cash Flow -118.2M -90.5M -70.1M -50.3M -25.2M
Investing Activities
Capital Expenditures -29.5M -34.2M -1.8M -5.2M -5.5M
Investing Cash Flow 20.4M -330.0M -1.7M -5.2M -5.5M
Financing Activities
Dividends Paid - - - - -
Financing Cash Flow 144.3M -9.6M 513.5M 71.5M 20.0M
Free Cash Flow -155.9M -124.3M -78.9M -55.5M -30.6M

Cash Flow Trend

ProKidney Key Financial Ratios

Valuation Ratios

P/E Ratio (TTM) -1.04
Forward P/E -1.27
Price to Book 0.22
Price to Sales 6,304.00
PEG Ratio -1.27

Profitability Ratios

Profit Margin 0.00%
Operating Margin -17,994.78%
Return on Equity -45.28%
Return on Assets -28.29%

Financial Health

Current Ratio 10.96
Debt to Equity 0.91
Beta 1.46

Per Share Data

EPS (TTM) -$0.59
Book Value per Share -$7.71
Revenue per Share $0.00

Peer Financial Comparison

Company Market Cap P/E Ratio P/B Ratio ROE Profit Margin Debt/Equity
prok 1.9B -1.04 0.22 -45.28% 0.00% 0.91
Vertex 114.1B 32.82 6.92 -5.64% -8.91% 10.00
Regeneron 55.3B 13.02 1.84 15.96% 31.94% 9.20
Vera Therapeutics 1.4B -8.41 2.58 -39.49% 0.00% 10.18
Immunocore Holdings 1.6B -31.41 4.13 -5.86% -6.48% 114.67
Agios 1.9B 2.89 1.32 60.26% 1,798.26% 3.61

Financial data is updated regularly. All figures are in the company's reporting currency.